IMOD

Rose Pharmed is an Iranian biotechnology company primarily known for the development and commercialization of IMOD (Immuno-Modulator Drug), a patented herbal therapeutic used as an adjunct treatment for HIV/AIDS. The company's lead product, IMOD, is a complex mixture of extracts from Rosa canina, Urtica dioica, and Tanacetum vulgare, supplemented with selenium, and is designed to strengthen the immune system by increasing CD4+ T-cell counts. Beyond HIV, Rose Pharmed has explored the application of its immunomodulatory technology in inflammatory conditions such as sepsis and ulcerative colitis. The company operates within the Iranian pharmaceutical ecosystem and has engaged in international collaborations to expand the reach of its herbal-based medicines.